Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
about
Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthmaMometasone furoate in the management of asthma: a reviewMometasone furoate nasal spray: a systematic reviewImproved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.Mometasone furoate dry powder inhaler for the treatment of asthma.Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma.The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.One-year treatment with mometasone furoate in chronic obstructive pulmonary diseaseInhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients.Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
P2860
Q24634033-64555639-DD79-490C-BBF8-A71A2F417A22Q24652990-5E796587-0F22-46F0-B017-F5C830D6EC59Q26747719-BD0FC4CC-39E9-48A5-A9F5-174AF34EF199Q33522061-A27E7A1A-EF9C-4F2E-89F9-0EE7FBA67258Q34633474-255A5AF3-904D-4395-905F-B929DE3B7AA5Q35818440-5B088866-DA4C-491D-89EC-700CBE07AF2AQ36684524-432A06A7-67A8-49D3-9D35-F8E36C695943Q37101342-2F491A78-90FA-46E0-8DD3-738AE4127D20Q37313138-83A54DDA-9683-4B09-9071-707817E17DE1Q37556510-EEE2E0EE-6C49-44DB-98D5-C76CF18F92CFQ42603944-C425A549-9C40-4474-A0E0-EFC3397ADF80Q42909622-227803B8-9E16-4BAB-AB73-735EFCA95072Q43718488-0A9E2ADE-B320-4DD0-82CA-7606150447FCQ44927006-2FF548BA-1A45-4BA7-839A-449A6DC3457DQ46786774-4F61678B-2367-418B-BCE9-2400081C8AECQ48943114-C390CE90-8767-43A9-8F3C-45FD546A9015Q51138515-7F231A4B-D0D3-4280-9F93-5378D4D69523
P2860
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Once-daily mometasone furoate ...... tients with persistent asthma.
@ast
Once-daily mometasone furoate ...... tients with persistent asthma.
@en
Once-daily mometasone furoate ...... tients with persistent asthma.
@nl
type
label
Once-daily mometasone furoate ...... tients with persistent asthma.
@ast
Once-daily mometasone furoate ...... tients with persistent asthma.
@en
Once-daily mometasone furoate ...... tients with persistent asthma.
@nl
prefLabel
Once-daily mometasone furoate ...... tients with persistent asthma.
@ast
Once-daily mometasone furoate ...... tients with persistent asthma.
@en
Once-daily mometasone furoate ...... tients with persistent asthma.
@nl
P2093
P1476
Once-daily mometasone furoate ...... tients with persistent asthma.
@en
P2093
Feinstein BK
Floreani A
Friedman BF
Goldsobel A
Gottschlich GM
Hannaway PJ
Harrison JE
P304
P356
10.1016/S1081-1206(10)62275-2
P577
2000-04-01T00:00:00Z